Abstracts tagged "COVID-19"

Abstract Number: 1279 • ACR Convergence 2020
Clinical Characteristics and Impact of the COVID-19 Pandemic in Systemic Lupus Erythematosus Patients in a Spanish Tertiary Hospital
Andrea Briones-Figueroa¹, María Jesús García-Villanueva², África Andreu Suárez¹, Marina Tortosa-Cabañas², Ana Corral-Bote², Sandra Garrote-Corral², Javier Bachiller-Corral¹ and Mónica Vázquez¹, ¹Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, ²Hospital Universitario Ramón y Cajal, Madrid, Spain
Background/Purpose: Data about incidence, clinical characteristics and outcome of patients with Systemic Lupus Erythematosus (SLE) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease is…
Abstract Number: 1685 • ACR Convergence 2020
Impact of the COVID-19 Pandemic Among Children with Rheumatic Diseases from Around the Globe
Jonathan Hausmann¹, Kevin Kennedy², Salman Surangiwala³, Maggie Larche⁴, Karen Durrant⁵, Rashmi Sinha⁶ and Emily Sirotich⁴, ¹Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, ²McMaster University, Hamilton, Canada, ³Queen’s School of Medicine, Kingston, Canada, ⁴McMaster University, Hamilton, ON, Canada, ⁵Autoinflammatory Alliance, San Francisco, CA, ⁶SJIA Foundation, Cincinnati
Background/Purpose: Children with rheumatic diseases face unknown risks in the setting of the COVID-19 pandemic. These children are often immunosuppressed due to their underlying disease…
Abstract Number: 0015 • ACR Convergence 2020
COVID -19 Lung Inflammation – What Have We Learnt so Far ?
Sriya Gokaraju¹, Maria Darda², Vinod Vijayaraghavan Nalini Warrier³, Irina Duta³, Fiona Hayes³, Yasser Ahmed⁴ and Gouri Koduri³, ¹Southend University Hospital NHS Trust, Essex, United Kingdom, ²Southend University Hospital NHS Trust, Essex, United Kingdom, ³Southend University Hospital NHS Trust, Essex, United Kingdom, ⁴Southend University Hospital, Essex, United Kingdom
Background/Purpose: The SARS CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of pneumonia and Acute Respiratory Distress Syndrome (ARDS). SARS CoV-2 in…
Abstract Number: 0435 • ACR Convergence 2020
Low Incidence of Coronavirus Disease 2019 (COVID-19) Infection in Patients on Biologic Infusion Therapies at a Community Rheumatology Practice
Julie Keegan Strosser¹, Ronald Yglesias² and Norman Gaylis¹, ¹Arthritis & Rheumatic Disease Specialties, Aventura, FL, ²Arthritis & Rheumatic Disease Specialties, Hialeah, FL
Background/Purpose: Following the first documented Florida case of COVID-19 on March 1, 2020, our community rheumatology practice continued to administer biologic infusion therapy with concern…
Abstract Number: 0595 • ACR Convergence 2020
High Satisfaction with Tele-medicine in a New York City Clinic
Tommy Chen¹, Cathy Guo¹, Wei Tang¹, Leila Khalili¹ and Anca Askanase², ¹Columbia University Medical Center, New York, NY, ²Columbia University College of Physicians & Surgeons, New York, NY
Background/Purpose: The face of medicine is changing with the time. A twenty-first century technological revolution in medicine happened in March 2020 as the COVID-19 pandemic…
Abstract Number: 0639 • ACR Convergence 2020
Immunological Abnormalities in a SARS-CoV-2-Cytokine Release Syndrome Rheumatology Cohort
Patil Injean¹, Sandy Lee¹, Neha Chiruvolu², Muntarin Karim³, Loomee Doo⁴, Deepa Ragesh Panikkath⁵, Donna Jose⁴, Micah Yu⁴, Anna Lafian⁴, Vaneet Sandhu⁶, Karina Torralba⁷, Christina Downey¹, Marven Cabling⁸ and Mehrnaz Hojjati⁹, ¹Loma Linda University Medical Center, Redlands, CA, ²UC Riverside School of Medicine, Riverside, CA, ³Loma Linda University Health System, Loma Linda, CA, ⁴Loma Linda University Medical Center, Loma Linda, CA, ⁵Loma Linda University Health, Department of Rheumatology, Loma Linda, CA, ⁶Loma Linda University, Loma Linda, CA, ⁷Loma Linda University School of Medicine, Redlands, CA, ⁸Loma Linda University Medical Center, Loma Linda, ⁹Loma Linda University, Loma Linda
Background/Purpose: Cytokine release syndrome (CRS) is a condition characterized by a sepsis-like condition and laboratory abnormalities such as high ferritin, low ESR, and low fibrinogen…
Abstract Number: 1280 • ACR Convergence 2020
COVID-19 Infections May Increase the Risk of SLE Flares
Leila Khalili¹, Yevgeniya Gartshteyn², Nancyanne Schmidt³, Teja Kapoor⁴, Laura Geraldino-Pardilla⁵ and Anca Askanase³, ¹Columbia University Medical Center, New York, NY, ²Columbia University College of Physicians and Surgeons, Glen Rock, NJ, ³Columbia University College of Physicians and Surgeons, New York, NY, ⁴Columbia University College of Physicians and Surgeons, Leonia, NJ, ⁵Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York
Background/Purpose: COVID-19 has overwhelmed the healthcare systems in New York City. Initial data from the Columbia Lupus Cohort suggests that 4% of patients with systemic…
Abstract Number: 1686 • ACR Convergence 2020
The COV-ASAKI Survey from the Pediatric Tuscany Network During COVID-19 Era
Maria Vincenza Mastrolia¹, Rino Agostiniani², Chiara Azzari³, Roberto Bernardini⁴, Ugo Bottone⁵, Giovanni Battista Calabri⁶, Flavio Civitelli⁷, Rita Consolini⁸, Roberto Danieli⁹, Rosalia Di Silvio¹⁰, Susanna Falorni¹¹, Luigi Gagliardi¹², Salvatore Grosso¹³, Marco Martini¹⁴, Graziano Memmini¹⁵, Marco Pezzati¹⁶, Giovanni Suriano¹⁷, Luca Tafi¹⁸, Angelina Vaccaro¹⁹, Pier Luigi Vasarri²⁰ and Gabriele Simonini²¹, ¹Rheumatology Unit, Meyer Children's University Hospital, Firenze, Italy, Florence, Toscana, Italy, ²Paediatric Unit, San Jacopo Hospital, Pistoia, Italy, Pistoia, Toscana, Italy, ³Paediatric Immunology Unit, Department of Health Sciences, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, ⁴Paediatric Unit, San Giuseppe Hospital, Empoli, Italy, Empoli, Toscana, Italy, ⁵Division of Neonatology and Pediatrics, Lotti Hospital, Pontedera, AUSL Toscana Nord Ovest, Pisa, Italy, Pisa, Toscana, Italy, ⁶Cardiologic Unit, Meyer Children’s University Hospital, Firenze, Italy, Florence, Toscana, Italy, ⁷Division of Neonatology and Pediatrics, Montepulciano Hospital, Montepulciano, AUSL Sud Est Toscana, Siena, Italy., Siena, Toscana, Italy, ⁸Section of clinical and laboratory Immunology, Department of clinical and experimental Medicine, University of Pisa, Italy, Pisa, Italy, ⁹Division of Neonatology and Pediatrics, Spedali Riuniti di Livorno, Livorno, AUSL Toscana Nord Ovest, Pisa, Italy, Livorno, Toscana, Italy, ¹⁰Paediatric Unit, Mugello Hospital, Borgo San Lorenzo, Firenze, Italy, Florence, Toscana, Italy, ¹¹Paediatric Unit, Misericordia Hospital, Grosseto, Italy, Grosseto, Italy, ¹²Division of Neonatology and Pediatrics, Ospedale Versilia Hospital, Viareggio, AUSL Toscana Nord Ovest, Pisa, Italy, Viareggio, Toscana, Italy, ¹³Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy, Siena, Toscana, Italy, ¹⁴Paediatric Unit, San Donato Hospital, Arezzo, Italy, Arezzo, Toscana, Italy, ¹⁵Division of Neonatology and Pediatrics, Apuane Hospital, Massa Carrara, AUSL Toscana Nord Ovest, Pisa, Italy, Massa Carrara, Toscana, Italy, ¹⁶Paediatric Unit, Santa Maria Annunziata Hospital, Bagno a Ripoli, Firenze, Italy, Florence, Toscana, Italy, ¹⁷Division of Neonatology and Pediatrics, Cecina Hospital, Cecina, AUSL Toscana Nord Ovest, Pisa, Italy, Cecina, Toscana, Italy, ¹⁸Paediatric and Neonatal Unit, Valdarno Hospital, Montevarchi, Arezzo, Italy, Arezzo, Toscana, Italy, ¹⁹Division of Neonatology and Pediatrics, San Luca Hospital, Lucca, AUSL Toscana Nord Ovest, Pisa, Italy, Lucca, Toscana, Italy, ²⁰Paediatric and Neonatologic Unit, Santo Stefano Hospital, Prato, Italy, Prato, Toscana, Italy, ²¹Rheumatology Unit, Meyer Children's University Hospital, Florence; NEUROFARBA Department, University of Florence, Italy, Florence, Italy
Background/Purpose: At the end of April 2020, national and international Pediatrics scientific societies diffused an alert about a rise in the number of pediatric severe,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].